FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Naslund

Research Profile

Disorders

Geographic Areas

United States

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Brian T Helfand; Jeanette Y Lee; Kevin T McVary; Michael J Naslund; Victoria Sharp; O Dale Williams; Harris Foster
Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial.
Robert S Hudson; Arthur A Hurwitz; Dong H Lee; Michael J Naslund; Robert M Stephens; Stephanie K Watkins; Harris G Yfantis; Ming Yi; James F Borin; Carlo M Croce; Tiffany H Dorsey; Dominic Esposito; Richard B Alexander; Sharon Anneve Glynn
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.
Michael J Barry; Joseph M Betz; Alan Cantor; E David Crawford; Harris E Foster; Steven A Kaplan; Karl J Kreder; John W Kusek; Jeannette Y Lee; Andrew McCullough; Kevin T McVary; Sreelatha Meleth; Catherine M Meyers; Michael J Naslund; J Curtis Nickel; Claus G Roehrborn; O Dale Williams; Gerald L Andriole; Andrew L Avins
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Naslund (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brian T Helfand; Jeanette Y Lee; Kevin T McVary; Michael J Naslund; Victoria Sharp; O Dale Williams; Harris Foster
Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial.
The Journal of urology 2012;188(6):2288-93.
2012: Robert S Hudson; Arthur A Hurwitz; Dong H Lee; Michael J Naslund; Robert M Stephens; Stephanie K Watkins; Harris G Yfantis; Ming Yi; James F Borin; Carlo M Croce; Tiffany H Dorsey; Dominic Esposito; Richard B Alexander; Sharon Anneve Glynn
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.
Nucleic acids research 2012;40(8):3689-703.
2011: Michael J Barry; Joseph M Betz; Alan Cantor; E David Crawford; Harris E Foster; Steven A Kaplan; Karl J Kreder; John W Kusek; Jeannette Y Lee; Andrew McCullough; Kevin T McVary; Sreelatha Meleth; Catherine M Meyers; Michael J Naslund; J Curtis Nickel; Claus G Roehrborn; O Dale Williams; Gerald L Andriole; Andrew L Avins
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
JAMA : the journal of the American Medical Association 2011;306(12):1344-51.
2011: Brian T Helfand; Kevin T McVary; Sreelatha Meleth; Victoria Sharp; Harris Foster; Michael J Naslund; O Dale Williams
The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial.
The Journal of urology 2011;185(6):2223-8.
2010: J Sausville; Michael J Naslund
Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
International journal of clinical practice 2010;64(13):1740-5.
2009: Jeannette Lee; Gerald Andriole; Andrew Avins; E David Crawford; Harris Foster; Steven Kaplan; Karl Kreder; John Kusek; Andrew McCullough; Kevin McVary; Sreelatha Meleth; Michael J Naslund; J Curtis Nickel; Leroy Nyberg; Claus Roehrborn; O Dale Williams; Michael Barry
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Clinical trials (London, England) 2009;6(6):628-36.
2009: Michael J Naslund; Michael T Eaddy; Susan L Hogue; Eric J Kruep; Manan B Shah
Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Current medical research and opinion 2009;25(11):2663-9.
2008: Michael J Naslund; Michael T Eaddy; Eric J Kruep; Susan L Hogue
Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.
The American journal of managed care 2008;14(5 Suppl 2):S167-71.
2008: Michael J Naslund; Timothy S Regan; Christine Ong; Susan L Hogue
5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives.
The American journal of managed care 2008;14(5 Suppl 2):S148-53.
2007: Michael J Naslund; A W Gilsenan; K D Midkiff; A Bown; E T Wolford; J Wang
Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
International journal of clinical practice 2007;61(9):1437-45.
2007: Michael J Naslund; Libby Black; Michael T Eaddy; LaKeasha R Batiste
Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs.
The American journal of managed care 2007;13 Suppl 1():S17-22.
2007: Michael J Naslund; Martin Miner
A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Clinical therapeutics 2007;29(1):17-25.
2006: Michael J Naslund; F J Costa; M M Miner
Managing enlarged prostate in primary care.
International journal of clinical practice 2006;60(12):1609-15.
2006: S Kaplan; Michael J Naslund
Public, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: A landmark national US survey.
International journal of clinical practice 2006;60(10):1157-65.
2006: Libby Black; Michael J Naslund; Thomas D Gilbert; E Anne Davis; Daniel A Ollendorf
An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.
The American journal of managed care 2006;12(4 Suppl):S99-S110.
2006: Thomas C Fenter; Michael J Naslund; Manan B Shah; Michael T Eaddy; Libby Black
The cost of treating the 10 most prevalent diseases in men 50 years of age or older.
The American journal of managed care 2006;12(4 Suppl):S90-8.
2006: Michael J Naslund; Evelyn Chiao; Libby Black; Michael T Eaddy
The hidden condition: status, challenges, and opportunities in the management of enlarged prostate for managed care.
The American journal of managed care 2006;12(4 Suppl):S76-82.
2006: Michael J Naslund; Muta M Issa; Amy L Grogg; Michael T Eaddy; Libby Black
Clinical and economic outcomes in patients treated for enlarged prostate.
The American journal of managed care 2006;12(4 Suppl):S111-6.
2005: Michael J Naslund; A M Carlson; M J Williams
A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.
The Journal of urology 2005;173(6):2090-3; discussion 2093.
2004: Brian Hill; William Belville; Reginald C Bruskewitz; Muta M Issa; Ramon Perez-Marrero; Claus G Roehrborn; Martha Kennedy Terris; Michael J Naslund
Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.
The Journal of urology 2004;171(6 Pt 1):2336-40.
2002: Ronald M Benoit; Barbara V Wise; Michael J Naslund; Ranjiv Mathews; Steven G Docimo
The effect of dysfunctional voiding on the costs of treating vesicoureteral reflux: a computer model.
The Journal of urology 2002;168(5):2173-6; discussion 2176.
2002: Young Kwok; Steven J DiBiase; Pradip Amin; Michael J Naslund; Geoffrey N Sklar; Stephen C Jacobs
Risk group stratification in patients undergoing permanent (125)I prostate brachytherapy as monotherapy.
International journal of radiation oncology, biology, physics 2002;53(3):588-94.
2002: Steven J DiBiase; Keya Hosseinzadeh; Rao P Gullapalli; Stephen C Jacobs; Michael J Naslund; Geoffrey N Sklar; Richard B Alexander; Cedric Yu
Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2002;52(2):429-38.
2001: Arif Hussain; Nancy A Dawson; Pradip Amin; Michael J Naslund; Christine Engstrom; T Chen
Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.
Seminars in oncology 2001;28(4 Suppl 15):22-31.
2000: Michael P O'Leary; William F Gee; HL Holtgrewe; Michael L Blute; Thomas P Cooper; BJ Miles; RE Nellans; Raju Thomas; M Ray Painter; JJ Meyer; Michael J Naslund; E Ann Gormley; Richard Blizzard; Randy B Fenninger
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.
The Journal of urology 2000;164(4):1311-6.
2000: JK Chon; Stephen C Jacobs; Michael J Naslund
The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer.
The Journal of urology 2000;164(3 Pt 1):735-7.
2000: Ronald M Benoit; Michael J Naslund; Jeffrey K Cohen
Complications after radical retropubic prostatectomy in the medicare population.
Urology 2000;56(1):116-20.
2000: Ronald M Benoit; Michael J Naslund; Jeffrey K Cohen
A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;47(4):909-13.
2000: Ranjiv Mathews; Michael J Naslund; Steven G Docimo
Cost analysis of the treatment of vesicoureteral reflux: a computer model.
The Journal of urology 2000;163(2):561-6; discussion 566-7.
2000: Ronald M Benoit; Michael J Naslund; Jeffrey K Cohen
Complications after prostate brachytherapy in the Medicare population.
Urology 2000;55(1):91-6.
1999: Michael P O'Leary; William F Gee; HL Holtgrewe; Michael L Blute; Thomas P Cooper; JJ Meyer; BJ Miles; Michael J Naslund; RE Nellans; Raju Thomas; M Ray Painter; Richard Blizzard; Randy B Fenninger
1998 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of ureteral stones and impact of managed care.
The Journal of urology 1999;162(5):1702-4.
1999: Claus G Roehrborn; F C Burkhard; Reginald C Bruskewitz; Muta M Issa; Ramon Perez-Marrero; Michael J Naslund; BP Shumaker
The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
The Journal of urology 1999;162(1):92-7.
1998: William F Gee; HL Holtgrewe; Michael L Blute; BJ Miles; Michael J Naslund; RE Nellans; Michael P O'Leary; Raju Thomas; M Ray Painter; JJ Meyer; T J Rohner; Thomas P Cooper; Richard Blizzard; Randy B Fenninger; L Emmons
1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.
The Journal of urology 1998;160(5):1804-7.
1998: Reginald C Bruskewitz; Muta M Issa; Claus G Roehrborn; Michael J Naslund; Ramon Perez-Marrero; BP Shumaker; JE Oesterling
A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
The Journal of urology 1998;159(5):1588-93; discussion 1593-4.
1998: Claus G Roehrborn; Muta M Issa; Reginald C Bruskewitz; Michael J Naslund; JE Oesterling; Ramon Perez-Marrero; BP Shumaker; Perinchery Narayan
Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.
Urology 1998;51(3):415-21.
1997: Ronald M Benoit; Michael J Naslund
The economics of prostate cancer screening.
Oncology (Williston Park, N.Y.) 1997;11(10):1533-43; discussion 1543, 1547-8.
1997: Michael J Naslund
Transurethral needle ablation of the prostate.
Urology 1997;50(2):167-72.
1997: Ronald M Benoit; Michael J Naslund
The socioeconomic implications of prostate-specific antigen screening.
The Urologic clinics of North America 1997;24(2):451-8.
1995: Geoffrey N Sklar; G M Koschorke; P S Filderman; Michael J Naslund; Stephen C Jacobs
Laparoscopic monitoring of cryosurgical ablation of the prostate.
Surgical laparoscopy & endoscopy 1995;5(5):376-81.
1995: R M Benoit; Michael J Naslund
Detection of latent prostate cancer from routine screening: comparison with breast cancer screening.
Urology 1995;46(4):533-6; discussion 536-7.
1994: R M Benoit; Michael J Naslund
An economic rationale for prostate cancer screening.
Urology 1994;44(6):795-803.
1994: Michael J Naslund
The economics of health care reform.
Urology 1994;44(3):299-304.
1993: T L Burney; Stephen C Jacobs; Michael J Naslund
Small bowel obstruction following laparoscopic lymphadenectomy.
The Journal of urology 1993;150(5 Pt 1):1515-7.
1993: J E Hader; L Marzella; R A Myers; Stephen C Jacobs; Michael J Naslund
Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis.
The Journal of urology 1993;149(6):1617-21.
1993: T L Burney; E C Campbell; Michael J Naslund; Stephen C Jacobs
Complications of staging laparoscopic pelvic lymphadenectomy.
Surgical laparoscopy & endoscopy 1993;3(3):184-90.
1993: R A Thompson; E W Campbell; H C Kramer; Stephen C Jacobs; Michael J Naslund
Late invasive recurrence despite long-term surveillance for superficial bladder cancer.
The Journal of urology 1993;149(5):1010-1.
1993: M S Steiner; Michael J Naslund; R E Stutzman
A modified thoracoabdominal approach for retroperitoneal lymphadenectomy.
The Journal of urology 1993;149(1):23-5.
1992: D M Quinlan; Michael J Naslund; Charles B Brendler
Application of argon beam coagulation in urological surgery.
The Journal of urology 1992;147(2):410-2.
1991: Michael J Naslund; S Dement; F F Marshall
Malignant renal schwannoma.
Urology 1991;38(5):477-9.
1991: R K Hildebrand; Michael J Naslund; J E Oesterling; Donald S Coffey
Influence of age, strain, and the testes on rat prostate hormone sensitivity.
The Prostate 1991;18(1):81-9.
1991: Stephen C Jacobs; E W Campbell; Michael J Naslund
Current status of cancers of the bladder and prostate.
Transactions of the Association of Life Insurance Medical Directors of America 1991;74():144-51.
1989: Michael J Naslund; John P Gearhart; RD Jeffs
Laparoscopy: its selected use in patients with unilateral nonpalpable testis after human chorionic gonadotropin stimulation.
The Journal of urology 1989;142(1):108-10.
1988: Michael J Naslund; J D Strandberg; Donald S Coffey
The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis.
The Journal of urology 1988;140(5):1049-53.
1986: Michael J Naslund; Donald S Coffey
The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth.
The Journal of urology 1986;136(5):1136-40.
1981: Michael J Naslund; Thomas A Pearson; J M Ritter
A documented episode of pulmonary vasoconstriction in systemic sclerosis.
The Johns Hopkins medical journal 1981;148(2):78-80.